HighTide Therapeutics, Inc.

SEHK:2511 Stock Report

Market Cap: HK$540.5m

HighTide Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2511 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Jun 24SellHK$71,050,210Shenzhen Hepalink Pharmaceutical Group Co., Ltd.Company37,730,500HK$1.88
11 Jun 24SellHK$1,739,068Shenzhen Hepalink Pharmaceutical Group Co., Ltd.Company404,500HK$4.30

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2511?
Owner TypeNumber of SharesOwnership Percentage
Institutions90,5000.0176%
Individual Insiders8,551,4681.66%
VC/PE Firms27,428,1545.33%
Private Companies48,479,5929.42%
Public Companies77,804,71015.1%
Employee Share Scheme81,000,00015.7%
General Public271,416,24452.7%

Dilution of Shares: 2511 only recently listed within the past 12 months


Top Shareholders

Top 11 shareholders own 47.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
HighTide Therapeutics, Inc, ESOP
81,000,000HK$85.0m0%no data
15.1%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
77,804,710HK$81.7m0%no data
8.88%
Hongtu Capital Limited
45,713,592HK$48.0m0%no data
5.33%
Shenzhen AIH Capital Management LLP
27,428,154HK$28.8m0%no data
0.96%
Liping Liu
4,956,631HK$5.2m0%no data
0.54%
Pingtan Rongjing Investment Partnership (Limited Partnership)
2,766,000HK$2.9m0%no data
0.34%
Meng Yu
1,748,688HK$1.8m0%no data
0.19%
Lixiong Ma
989,544HK$1.0m0%no data
0.17%
Xun Zhu
856,605HK$899.5k0%no data
0.017%
Bosera Asset Management Co., Ltd.
89,500HK$94.0k0%no data
0.00019%
E Fund Management Co., Ltd.
1,000HK$1.0k0%no data